The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric Oxide: An Overview
Abstract
Nitric oxide (NO) mediates multiple physiological and pathophysiological processes in the cardiovascular system. Pharmacological compounds that release NO have been useful tools for evaluating the pivotal role of NO in cardiovascular physiology and therapeutics. These agents constitute two broad classes of compounds, those that release NO or one of its redox congeners spontaneously and those that require enzymatic metabolism to generate NO. In addition, several commonly used cardiovascular drugs exert their beneficial action, in part, by modulating the NO pathway. Here, we review these classes of agents, summarizing their fundamental chemistry and pharmacology, and provide an overview of their cardiovascular mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Self-citationRajagopalan, S., Kurz, S., Münzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,449
NITRIC OXIDE: A Physiologic Messenger Molecule
Bredt, D. S., & Snyder, S. H. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.001135 · Cited by 2,368
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
Wink, D. A., & Mitchell, J. B. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00092-6 · Cited by 1,606
Stamler, J. S., Simon, D. I., Osborne, J. A., Mullins, M. E., Jaraki, O., Michel, T., Singel, D. J., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.444 · Cited by 1,471
Self-citationKureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Collins, R. T., Peto, R., Flather, M. D., Parish, S., Sleight, P., Conway, M. A., Pipilis, A., Baigent, C., Barnett, D., Boissel, J., et al. (1995) · Ghent University Academic Bibliography (Ghent University) · Cited by 1,115
Rajfer, J., Aronson, W. J., Bush, P. A., Dorey, F. J., & Ignarro, L. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260203 · Cited by 1,006
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 966
Nitric Oxide: A Physiologic Messenger
Lowenstein, C. J., Dinerman, J. L., & Snyder, S. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00009 · Cited by 907
Kojda, G. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00169-8 · Cited by 768
Nitric Oxide as a Signaling Molecule in the Vascular System: An Overview
Ignarro, L. J., Cirino, G., Casini, A., & Napoli, C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199912000-00016 · Cited by 763
Self-citationKeefer, L. K., Nims, R. W., Davies, K. M., & Wink, D. A. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)68030-6 · Cited by 670
Münzel, T., Sayegh, H., Freeman, B. A., Tarpey, M. M., & Harrison, D. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117637 · Cited by 655
Nitric Oxide Insufficiency, Platelet Activation, and Arterial Thrombosis
Loscalzo, J. (2001) · Circulation Research · doi:10.1161/hh0801.089861 · Cited by 612
Self-citationGruetter, C. A., Gruetter, D. Y., Lyon, J. E., Kadowitz, P. J., & Ignarro, L. J. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32778-3 · Cited by 533
Self-citationEndothelial Dysfunction: From Physiology to Therapy
Mombouli, J.-V., & Vanhoutte, P. M. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0844 · Cited by 503
Biological aspects of reactive nitrogen species
Patel, R. P., McAndrew, J., Sellak, H., White, C. R., Jo, H., Freeman, B. A., & Darley-Usmar, V. M. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00028-6 · Cited by 498
Gruetter, C. A., Barry, B. K., McNamara, D. B., Gruetter, D. Y., Kadowitz, P. J., & Ignarro, L. J. (1979) · PubMed · Cited by 444
Self-citationON THE USE OF NITRITE OF AMYL IN ANGINA PECTORIS.
Lauder Brunton, T. (1867) · The Lancet · doi:10.1016/s0140-6736(02)51392-1 · Cited by 411
Laufs, U., Fata, V. L., & Liao, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31725 · Cited by 387
Nitric Oxide and Atherosclerosis
Napoli, C., & Ignarro, L. J. (2001) · Nitric Oxide · doi:10.1006/niox.2001.0337 · Cited by 368
Self-citationNon-Enzymatic Nitric Oxide Synthesis in Biological Systems
Zweier, J. L., Samouilov, A., & Kuppusamy, P. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00018-3 · Cited by 363
The use of nitric oxide donors in pharmacological studies
Feelisch, M. (1998) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005231 · Cited by 347
Ignarro, L. J., Buga, G. M., Wei, L. H., Bauer, P. M., Wu, G., & del Soldato, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071054698 · Cited by 331
Self-citationNebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
Cockcroft, J. R., Chowienczyk, P. J., Brett, S. E., Chen, C. P., Dupont, A. G., Van Nueten, L., Wooding, S. J., & Ritter, J. M. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10549-1 · Cited by 324
Münzel, T., Kurz, S., Rajagopalan, S., Thoenes, M., Berrington, W. R., Thompson, J. A., Freeman, B. A., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118935 · Cited by 314
Overall cardiovascular profile of sildenafil citrate
Zusman, R. M., Morales, A., Glasser, D. B., & Osterloh, I. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00046-6 · Cited by 307
Scharfstein, J. S., Keaney, J. F., Slivka, A., Welch, G. N., Vita, J. A., Stamler, J. S., & Loscalzo, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117480 · Cited by 290
Self-citationNITRO-GLYCERINE AS A REMEDY FOR ANGINA PECTORIS.
Murrell, W. (1879) · The Lancet · doi:10.1016/s0140-6736(02)46032-1 · Cited by 289
Gupta, T. K., Toruner, M., & Groszmann, R. J. (1998) · Digestion · doi:10.1159/000007500 · Cited by 260
SULFHYDRYL REQUIREMENT FOR RELAXATION OF VASCULAR SMOOTH MUSCLE
Needleman, P., Jakschik, B., & Johnson, E. M. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29678-1 · Cited by 250
Zai, A., Rudd, M. A., Scribner, A. W., & Loscalzo, J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4890 · Cited by 234
Self-citationMünzel, T., Li, H., Mollnau, H., Hink, U., Matheis, E., Hartmann, M., Oelze, M., Skatchkov, M., Warnholtz, A., Duncker, L., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.1.e7 · Cited by 234
Marks, D. S., Vita, J. A., Folts, J. D., Keaney, J. F., Welch, G. N., & Loscalzo, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118328 · Cited by 230
Self-citationNitric Oxide-Releasing Polymers Containing the [N(O)NO]-Group
Smith, D. J., Chakravarthy, D., Pulfer, S., Simmons, M. L., Hrabie, J. A., Citro, M. L., Saavedra, J. E., Davies, K. M., Hutsell, T. C., Mooradian, D. L., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950652b · Cited by 208
Biocompatibility aspects of new stent technology
Bertrand, O. F., Sipehia, R., Mongrain, R., Rodés, J., Tardif, J.-C., Bilodeau, L., Côté, G., & Bourassa, M. G. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00289-7 · Cited by 201
Nitric oxide mediated venodilator effects of nebivolol.
Bowman, A., Chen, C., & Ford, G. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04342.x · Cited by 190
Webb, D. J., Muirhead, G. J., Wulff, M., Sutton, J. A., Levi, R., & Dinsmore, W. W. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00705-1 · Cited by 187
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin.
Loscalzo, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112024 · Cited by 187
Self-citationChung, S. J., & Fung, H. L. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13024-3 · Cited by 181
Wilson, S. H., Simari, R. D., Best, P. J. M., Peterson, T. E., Lerman, L. O., Aviram, M., Nath, K. A., Holmes, D. R., & Lerman, A. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.122 · Cited by 166
Interactions among ACE, kinins and NO
Linz, W. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00091-7 · Cited by 165
Nitric Oxide and the Cardiovascular System
Welch, G. N., & Loscalto, J. (1994) · Journal of Cardiac Surgery · doi:10.1111/j.1540-8191.1994.tb00857.x · Cited by 163
Direct Vascular Effects of HMG-CoA Reductase Inhibitors
Laufs, U. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00044-x · Cited by 158
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents
Soldato, P. D., Sorrentino, R., & Pinto, A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01353-x · Cited by 148
Murad, F. (1998) · PubMed · Cited by 136
Fitzhugh, A. L., & Keefer, L. K. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00251-3 · Cited by 134
Molina, C. R., Andresen, J. W., Rapoport, R. M., Waldman, S. A., & Murad, F. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198710000-00001 · Cited by 128
McGuire, J. J., Anderson, D. J., McDonald, B. J., Narayanasami, R., & Bennett, B. M. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00216-0 · Cited by 111
Järvisalo, M. J., Toikka, J., Vasankari, T. J., Mikkola, J., Viikari, J. S. A., Hartiala, J., & Raitakari, O. T. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00189-6 · Cited by 102
Ellis, A., Li, C. G., & Rand, M. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703058 · Cited by 100
In Vivo Antithrombotic Effects of a Nitric Oxide-Releasing Aspirin Derivative, NCX-4016
Wallace, J. L., Muscará, M. N., McKnight, W., Dicay, M. S., Soldato, P. D., & Cirino, G. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(98)00134-0 · Cited by 93
Schönafinger, K. (1999) · Il Farmaco · doi:10.1016/s0014-827x(99)00031-2 · Cited by 91
The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs
Wallace, J. L., & Cirino, G. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90083-3 · Cited by 88
Role of nitric oxide in the control of renin secretion
Kurtz, A., & Wagner, C. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.6.f849 · Cited by 88
What We Know and Don’t Know About l -Arginine and NO
Loscalzo, J. (2000) · Circulation · doi:10.1161/01.cir.101.18.2126 · Cited by 87
Self-citationEffects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice
Claudio Napoli, A., Cirino, G., Soldato, P. D., Sorrentino, R., Sica, V., Condorelli, M., Pinto, A., & Ignarro, L. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041602898 · Cited by 84
Self-citationBandarage, U. K., Chen, L., Fang, X., Garvey, D. S., Glavin, A., Janero, D. R., Letts, L. G., Mercer, G. J., Saha, J. K., Schroeder, J. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000178w · Cited by 81
Kurz, M. A., BOYER, T. D., Whalen, R., Peterson, T. E., & Harrison, D. G. (1993) · Biochemical Journal · doi:10.1042/bj2920545 · Cited by 79
Traish, A. M., Netsuwan, N., Daley, J., Padma-Nathan, H., Goldstein, I., & de Tejada, I. S. (1995) · The Journal of Urology · doi:10.1097/00005392-199501000-00081 · Cited by 75
Gruetter, C. A., Barry, B. K., McNamara, D. B., Kadowitz, P. J., & Ignarro, L. J. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32123-3 · Cited by 74
Self-citationPulfer, S. K., Ott, D. W., & Smith, D. J. B. (1997) · Journal of Biomedical Materials Research · Cited by 67
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin
Momi, S., Emerson, M., Paul, W., Leone, M., Mezzasoma, A. M., Soldato, P. D., Page, C. P., & Gresele, P. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00223-5 · Cited by 65
Weiss, R. H., RAMIREZ, A., & Joo, A. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1091880 · Cited by 64
Lechi, C., Andrioli, G., Gaino, S., Tommasoli, R., Zuliani, V., Ortolani, R., Degan, M., Benoni, G., Bellavite, P., Lechi, A., et al. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650662 · Cited by 63
The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces
Maalej, N. M., Albrecht, R. M., Loscalzo, J., & Folts, J. D. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00687-1 · Cited by 62
Self-citationEndothelial dysfunction and inhibition of converting enzyme.
Pm, V. (1998) · PubMed · Cited by 61
Nitrosylated Bovine Serum Albumin Derivatives as Pharmacologically Active Nitric Oxide Congeners
Ewing, J. F., Young, D. V., Janero, D. R., Garvey, D. S., & Grinnell, T. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37070-3 · Cited by 56
S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
Loscalzo, J., Smick, D., Andon, N., & Cooke, J. P. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23489-9 · Cited by 55
Self-citationDual Mode of Action of Dihydropyridine Calcium Antagonists: A Role for Nitric Oxide
Dhein, S., Salameh, A., Berkels, R., & Klaus, W. (1999) · Drugs · doi:10.2165/00003495-199958030-00002 · Cited by 53
Jacobs, B. R., Brilli, R. J., Ballard, E. T., PASSERINI, D. J., & Smith, D. J. B. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9802114 · Cited by 49
Sex and the patient with cardiovascular risk factors: focus on sildenafil
Kloner, R. A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00656-2 · Cited by 46
Urinary Nitrotyrosine Content as a Marker of Peroxynitrite-induced Tolerance to Organic Nitrates
Skatchkov, M. P., Larina, L. L., Larin, A. A., Fink, N., & Bassenge, E. (1997) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424849700200202 · Cited by 43
Fernández-Tomé, P., Lizasoaín, I., Leza, J. C., Lorenzo, P. L., & Moro, M. Á. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00069-6 · Cited by 38
Molecular multitasking: statins lead to more arteries, less plaque
Simons, M. (2000) · Nature Medicine · doi:10.1038/79646 · Cited by 36
THE USE OF INHALED NITRIC OXIDE IN A WIDE VARIETY OF CLINICAL PROBLEMS
Nelin, L. D., & Hoffman, G. M. (1998) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70026-2 · Cited by 36
Nitro-aspirin (NCX4016) reduces brain damage induced by focal cerebral ischemia in the rat
Fredduzzi, S., Mariucci, G., Tantucci, M., Soldato, P. D., & Ambrosini, M. V. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01672-x · Cited by 34
Stables, R., Flather, M. D., & Sigwart, U. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0816 · Cited by 34
P-Nitrosophosphate Compounds: New N−O Heterodienophiles and Nitroxyl Delivery Agents
Ware, R. W., & King, S. B. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo001230z · Cited by 33
Folate and Nitrate-Induced Endothelial Dysfunction: A Simple Treatment for a Complex Pathobiology
Loscalzo, J. (2001) · Circulation · doi:10.1161/circ.104.10.1086 · Cited by 32
Self-citationde Tejada, I. S., Garvey, D. S., Schroeder, J. D., Shelekhin, T. E., Letts, L. G., Fernández, A., Cuevas, B., Gabancho, S., Martínez, V. S., Angulo, J., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34875-x · Cited by 30
de Tejada, I. S., Garvey, D. S., Schroeder, J. D., et al. (1999) · PubMed · Cited by 29
Nitric Oxide and the Cardiovascular System
Loscalzo, J., & Vita, J. A. (2000) · Humana Press eBooks · doi:10.1385/1592590020 · Cited by 29
Self-citationAntiaggregating and vasodilatory effects of a new nitroderivative of acetylsalicylic acid
Minuz, P., Lechi, C., Tommasoli, R., et al. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00189-x · Cited by 21
Intrahepatic Modulation of Portal Pressure and Its Role in Portal Hypertension
Wheatley, A. M., & Zhang, X.-Y. (1998) · Digestion · doi:10.1159/000007503 · Cited by 20
Pranidipine Enhances the Action of Nitric Oxide Released From Endothelial Cells
Yang, J., Fukuo, K., Morimoto, S., Niinobu, T., Suhara, T., & Ogihara, T. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.82 · Cited by 18
Depletion of Intracellular Glutathione Reduces Mutations by Nitric Oxide-Donating Drugs
Birnboim, H. C., & Privora, H. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0304 · Cited by 12
Bradykinin metabolism in the isolated perfused rabbit heart
Taylor-McCabe, K. J., Erşahin, Ç. H., & Simmons, W. H. (2001) · Journal of Hypertension · doi:10.1097/00004872-200107000-00015 · Cited by 12
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Francis, S. H., Busch, J. L., & Corbin, J. D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002907 · Cited by 1,028
Nitric oxide release: Part II. Therapeutic applications
Carpenter, A. W., & Schoenfisch, M. H. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15273h · Cited by 964
Impact of albumin on drug delivery — New applications on the horizon
Elsadek, B., & Kratz, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 832
Metadata
- Authors
- Ignarro, L. J., Napoli, C., & Loscalzo, J.
- Venue
- Circulation Research
- Published
- 2002-01-11
- Volume
- 90
- Issue
- 1
- Pages
- 21-28
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W1971377175
- Cited by
- 491
- References
- 91
- FWCI
- 17.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.